FullText Few microorganisms can be credited with bringing so many contributions to the biomedical world and concomitantly inflicting so much pain as the pneumococcus.Streptococcus pneumoniae, one of the earliest pathogens characterized, contributed to the development of the Gram stain and the Quellung re...
There is low uptake of the pneumococcal vaccination in eligible older adults, even in high-income countries that offer routine and universal vaccination programs. To systematically characterize interventions aimed at improving pneumococcal vaccine uptake
While the recently authorized COVID-19 vaccines remain the most important strategy forpreventing COVID-19, investigators found that older adults who received pneumococcal conjugate vaccine (PCV13), which prevents acquisition of certain pneumococcal strains, experienced 35% lower risk of COVID-19 diagnos...
free access to vaccination and exhibited an overall high level of trust in vaccine safety, this observation suggests that lack of information about pneumococcal vaccination and improving access to healthcare services are critical targets for enhancing uptake in Italy. We observed gender differences in v...
Pfizer is testing a booster of its COVID-19 vaccine in combination with a pneumococcal vaccine candidate in fully vaccinated older adults. The study will analyze safety and the immune responses produced by each.
Q: Besides the importance of vaccines, concerns about side effects have increased since Covid-19. What are the trends in adverse event rates for pneumococcal conjugate vaccines in the 10 years since the introduction of NIPs? A:The vaccine's safety is assessed by separating mild and severe adve...
Define polyvalent pneumococcal vaccine. polyvalent pneumococcal vaccine synonyms, polyvalent pneumococcal vaccine pronunciation, polyvalent pneumococcal vaccine translation, English dictionary definition of polyvalent pneumococcal vaccine. n. 1. a. A pre
there have been transformational changes in the control of pneumonia and pneumococcal disease worldwide. This era has been defined by the introduction of pneumococcal conjugate vaccines globally, with a keen focus on assessing vaccine impact and serotype evolution. However, severe outcomes from pneumococc...
Pfizer COVID-19 vaccine. Courtesy: Pfizer The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier recommendation for vaccination was for adults 65 years o...
Pfizer recently announced positive top-line results from a Phase 3 trial studying its COVID-19 vaccine combined with its pneumococcal 20-valent conjugate vaccine, Prevnar 20.